Le Lézard
Classified in: Health
Subjects: NPT, CSR

Association for the Advancement of Wound Care (AAWC) Recognizes 2017 Corporate Sponsors and Announces Open Enrollment for the 2018 Sponsorship Program



MALVERN, Pa., Jan. 3, 2018 /PRNewswire-USNewswire/ -- The Association for the Advancement of Wound Care (AAWC) is pleased to acknowledge the generous support of its 2017 corporate sponsors and announces open enrollment for the 2018 sponsorship program.

AAWC is the leading, nonprofit organization in the United States dedicated to interdisciplinary wound healing and tissue preservation. With a mission to advance the care of people with and at risk for wounds, AAWC offers membership to everyone involved in wound care - clinicians, researchers, educators and other healthcare professionals; patients and lay-caregivers; clinics, hospitals and other healthcare facilities; corporations and manufacturers; students and retirees; and advocates. (PRNewsFoto/AAWC)

Corporate support is vital for sustaining the AAWC's valued, evidence-based and patient-focused programs and activities. The 2017 AAWC Corporate Sponsors include: Acelity, Molnlycke, Smith & Nephew, 3M, Convatec, Hollister, Integra Life Sciences, Medline, Osiris Therapeutics, BioCompression Systems, Boyd Technologies, MiMedx and Wellsense.

AAWC Corporate Sponsorship provides lucrative benefits based on level of support, including the exclusive opportunity for industry sponsors to meet with AAWC officers and other key wound care industry leaders at quarterly Corporate Advisory Panel meetings. As stakeholders with a common purpose of helping patients, the panel focuses on education and public awareness, with the ultimate goal of elevating standards of wound care practice worldwide.

Additionally, through AAWC's strong, dedicated Healthcare Public Policy Committee, sponsors receive unbiased wound care information, alerts and support on matters of US government and regulatory affairs.

The Association's 2018 sponsorship campaign is underway. To learn more about the program, visit the AAWC website.

In related news, the first ever AAWC Pressure Ulcer (PrU) Summit is taking place February 9 - 10, 2018 in Atlanta, GA. The Summit brings together an international forum of leaders in wound care and pressure ulcer prevention and management to present the latest research in the field with an emphasis on clinical implementation. Learn more about the PrU Summit Program and the exciting opportunities for industry involvement.

ABOUT AAWC - AAWC is the leading, nonprofit membership organization in the US dedicated to inter-professional wound healing and tissue preservation. The Association's focus is on education, public policy, and the application of evidence-based wound care practice. AAWC offers membership and associated benefits to everyone involved in wound care, including clinicians and other healthcare professionals, patients, lay-caregivers, clinics/facilities, corporations, students, retirees, and advocates. There are numerous ways that one can make a difference at AAWC. Visit the AAWC website to learn more or complete an application.

 

SOURCE Association for the Advancement of Wound Care


These press releases may also interest you

at 13:54
Premiers discussed ways to improve health care for Canadians. Their discussions focused on pharmacare, addictions and mental health, healthy aging and collaborating on health care procurement. Premiers reiterated their concerns over the declining...

at 13:43
Progress in treating acute myeloid leukemia (AML), a blood cancer that takes more than 10,000 lives in the United States each year, took an important step forward today with the U.S. Food & Drug Administration (FDA) approval of ivosidenib (Tibsovo®)...

at 13:30
The "Peripheral Vascular Stent Market | US | Units Sold, Average Selling Prices, Forecasts | 2018-2024| MedCore" report has been added to ResearchAndMarkets.com's offering. There will be an increase in peripheral stenting procedure numbers, which...

at 13:22
The U.S. Food and Drug Administration was notified by Bayer that the Essure permanent birth control device will no longer be sold or distributed after December 31, 2018. This decision follows the FDA's patient safety action in April, in which the...

at 13:15
The "Inferior Vena Cava Filter & Retrieval Device Market | US | Units Sold, Average Selling Prices, Forecasts | 2018-2024| MedCore" report has been added to ResearchAndMarkets.com's offering. The ASP of all segments of the total market are expected...

at 13:15
NAPLES, Fla., July 20, 2018 /PRNewswire-PRWeb/ -- Dr. Joseph V. Pergolizzi, Jr., CEO of Native Cardio, Inc., will concentrate his efforts on developing groundbreaking medical devices for cardiology patients after retiring and resigning as a part-time...




News published on 3 january 2018 at 10:11 and distributed by: